All lobbying filings
BALLARD PARTNERS
BALLARD PARTNERS filed a Q3 report for MADRIGAL PHARMACEUTICALS, INC. on October 18, 2026, reporting $120,000 in lobbying income.
Lobbying for MADRIGAL PHARMACEUTICALS, INC. · Biopharmaceutical company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 18, 2026
Income
$120,000
What the client paid this registrant for the period.
Client based in
Pennsylvania
Lobbyists on this filing
1
-
ALISON ANWAYPreviously held: LA to Senator Pat Roberts 2006-2010
Lobbying activity
1
Advocacy related to prescription drug access and pricing.